 |
|
Risk factors in nonalcoholic fatty liver disease
Eunji Ko, Eileen L. Yoon, Dae Won Jun
Clin Mol Hepatol. 2023;29(Suppl):S79-S85. Published online 2022 Dec 14 DOI: https://doi.org/10.3350/cmh.2022.0398
|
|
Citations to this article as recorded by
 Quantitative Liver Fat Assessment by Handheld Point-of-Care Ultrasound: A Technical Implementation and Pilot Study in Adults
Dorathy Tamayo-Murillo, Jake T. Weeks, Cody A. Keller, Michael Andre, Celene Gonzalez, Andrew Li, Eduardo Grunvald, Joy Liau, Sedighe Hosseini Shabanan, Tanya Wolfson, Jingyi Zuo, Adam Robinson, Carolina Amador Carrascal, Nevada Sanchez, Scott B. Reeder,
Ultrasound in Medicine & Biology.2025; 51(3): 475. CrossRef Decompensated Cirrhosis with Hepatopulmonary Syndrome in a Patient with Interrupted Treatment for Hypopituitarism: A Case Report
Tomoko Tadokoro, Joji Tani, Yudai Sato, Rie Yano, Kei Takuma, Mai Nakahara, Kyoko Oura, Koji Fujita, Masafumi Ono, Atsushi Tobiume, Seisuke Sato, Takuya Inoue, Asahiro Morishita, Hideki Kobara
Internal Medicine.2025;[Epub] CrossRef Smoking and Risk of Fatty Liver Disease: A Meta-Analysis of Cohort Studies
Moonhyung Lee, Seung-Kwon Myung, Sang Hee Lee, Yoosoo Chang
Gastroenterology Insights.2025; 16(1): 1. CrossRef Is type 2 diabetes a link between lung function and metabolic dysfunction–associated steatotic liver disease? Insights from population studies and Mendelian randomization
Runmin Cao, Yurun Zhang, Ling Cao, Honghe Jiang
European Journal of Gastroenterology & Hepatology.2025;[Epub] CrossRef Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome Analysis
Gina Ryu, Eileen Laurel Yoon, Wankyu Kim, Dae Won Jun
Diagnostics.2025; 15(3): 342. CrossRef A novel 11β-HSD1 inhibitor ameliorates liver fibrosis by inhibiting the notch signaling pathway and increasing NK cell population
Ji Eun Kim, Yun Kim, Jiwon Bae, Eileen Laurel Yoon, Hyun Sung Kim, Sung Ryol Lee, Tae Hyun Yoon, Dae Won Jun
Archives of Pharmacal Research.2025; 48(2): 166. CrossRef Transcriptomic analysis reveals the mechanisms underlying the differential effects of caffeine, theophylline, and theobromine in regulating hepatic fat accumulation
Jinya Dong, Xiaocui Du, Ruijuan Yang, Linxian Shan, Xiuli Lu, Yan Shen, Yanmei Li, Shengjie Duan, Zezhu Du, Jianyang Fu, Jun Sheng, Chongye Fang
Food & Function.2025; 16(6): 2503. CrossRef Epidemiological dynamics of burden and health inequalities in metabolic dysfunction-associated steatotic liver disease in adolescents at global, regional, and national levels, 1990-2021
Xiaohui Sui, Junde Zhao, Yuxin Yang, Yikun Yang, Kaifeng Li, Zuocheng Wang, Ziqi Liu, Ruining Lu, Guiju Zhang
Journal of Clinical and Experimental Hepatology.2025; : 102537. CrossRef The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Ian Homer Cua, Chun-Jen Liu, Tawesak Tanwandee, Rino Gani, Wai-Kay Seto, Shahinul Alam, Dan Yock Young, Saeed Hamid, Ming-Hua Zheng, Takumi Kawaguchi, Wah-Kheong Chan, Diana Payawal, Soek-S
Hepatology International.2025;[Epub] CrossRef Association between serum trace element, mineral, and amino acid levels with non-alcoholic fatty liver disease (NAFLD) in adult women
Alexey A. Tinkov, Tatiana V. Korobeinikova, Galina D. Morozova, Michael Aschner, Daria V. Mak, Abel Santamaria, Joao B.T. Rocha, Tatiana I. Sotnikova, Serafima Ia. Tazina, Anatoly V. Skalny
Journal of Trace Elements in Medicine and Biology.2024; 83: 127397. CrossRef Adverse pregnancy outcomes as a risk factor for new-onset metabolic dysfunction-associated steatotic liver disease in postpartum women: A nationwide study
Young Mi Jung, Seung Mi Lee, Wonyoung Wi, Min-Jeong Oh, Joong Shin Park, Geum Joon Cho, Won Kim
JHEP Reports.2024; 6(4): 101033. CrossRef Hybrid Quantum Image Classification and Federated Learning for Hepatic Steatosis Diagnosis
Luca Lusnig, Asel Sagingalieva, Mikhail Surmach, Tatjana Protasevich, Ovidiu Michiu, Joseph McLoughlin, Christopher Mansell, Graziano de’ Petris, Deborah Bonazza, Fabrizio Zanconati, Alexey Melnikov, Fabio Cavalli
Diagnostics.2024; 14(5): 558. CrossRef Characterisation and beneficial effects of a Lupinus angustifolius protein hydrolysate obtained by immobilisation of the enzyme alcalase®
Guillermo Santos-Sánchez, Ivan Cruz-Chamorro, José Carlos Márquez-López, Justo Pedroche, Ana Isabel Álvarez-López, María del Carmen Millán-Linares, Patricia Judith Lardone, Antonio Carrillo-Vico
Food & Function.2024; 15(7): 3722. CrossRef Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences
Joo Hyun Oh, Dae Won Jun
Clinical and Molecular Hepatology.2024; 30(2): 168. CrossRef Gestational supplementation of Bifidobacterium, Lactobacillus, and Streptococcus thermophilus attenuates hepatic steatosis in offspring mice through promoting fatty acid β‐oxidation
Hangjun Chen, Qiongmei Wu, Xingyi Chen, Xinxue Yu, Hanqing Zhao, Qiaoli Huang, Yurong Huang, Jinting Wang, Xueyi Huang, Jun Wei, Feng Wu, Xiaomin Xiao, Lijun Wang
Journal of Food Science.2024; 89(5): 3064. CrossRef Polyethersulfone Polymer for Biomedical Applications and Biotechnology
Monika Wasyłeczko, Cezary Wojciechowski, Andrzej Chwojnowski
International Journal of Molecular Sciences.2024; 25(8): 4233. CrossRef The gut-liver axis in fatty liver disease: role played by natural products
Zhu Ming, Xie Ruishi, Xu Linyi, Yang Yonggang, Luo Haoming, Lan Xintian
Frontiers in Pharmacology.2024;[Epub] CrossRef Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction‐associated fatty liver disease: A cross‐sectional study of NHANES 2017–2018
Zhiliang Mai, Yinfei Chen, Hua Mao, Lisheng Wang
Journal of Diabetes.2024;[Epub] CrossRef Association between hemoglobin and non-alcoholic fatty liver disease (NAFLD) in United States adults: Results from NHANES 2017–2020
Kang Yao, Zheng Chen, Wei Zhou, Zhihua Liu, Wei Cui
Preventive Medicine Reports.2024; 44: 102798. CrossRef Metabolic dysfunction–associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity
Jie Tao, Hong Li, Honggang Wang, Juan Tan, Xiaozhong Yang
Osteoporosis International.2024; 35(12): 2087. CrossRef Knowledge, Attitudes, and Determinants of Nonalcoholic Fatty Liver Disease Among Adults in Jazan Province: A Cross-Sectional Study
Ali M Someili, Mostafa Mohrag, Bandar S Rajab, Abdulrahman A Daghreeri, Fawaz M Hakami, Riyadh A Jahlan, Abdulrahman A Otaif, Abdulelah A Otaif, Hussam T Hakami, Bandar F Daghriri, Ameer M Mobarki, Rakan B Almjlad, Mousa Mobarki
Cureus.2024;[Epub] CrossRef Reply to correspondence on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”
Eileen Laurel Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2024; 30(4): 1033. CrossRef Silybin: A Review of Its Targeted and Novel Agents for Treating Liver Diseases Based on Pathogenesis
Jijiao Wu, Lin Wen, Xiaolian Liu, Qiuxia Li, Zihao Sun, Chuipeng Liang, Fan Xie, Xiaofang Li
Phytotherapy Research.2024; 38(12): 5713. CrossRef Acute Toxicity and Hepatoprotective Influence of Hypericum perforatum Against Thioactamid-Induced Liver Fibrosis in Rats
Ahmed A.J. Jabbar, Zaenah Zuhair Alamri
Natural Product Communications.2024;[Epub] CrossRef The Role of Dietary Ingredients and Herbs in the Prevention of Non-Communicable Chronic Liver Disease
Monika Maćków, Tomasz Dziubyna, Tatiana Jamer, Dmytro Slivinskyi, Tomasz Pytrus, Katarzyna Neubauer, Małgorzata Zwolińska-Wcisło, Andrzej Stawarski, Ewa Piotrowska, Dorian Nowacki
Nutrients.2024; 16(20): 3505. CrossRef Phytochemical Profiling, Acute Toxicity, and Hepatoprotective Effects of Anchusa Limbata in Thioacetamide‐Induced Liver Cirrhosis in Rats
Khaled Abdul‐Aziz Ahmed, Ahmed A. J. Jabbar, Mohammed M. Hussein M. Raouf, Ayman M. Al‐Qaaneh, Rawaz Rizgar Hassan, Musher Ismael Salih, Ramzi A. Mothana, Gadah Abdulaziz Al‐Hamoud, Mahmood Ameen Abdulla, Sidgi Hasson, Parween Abdul‐samad Ismail
Food Science & Nutrition.2024; 12(12): 10628. CrossRef Quantificação da gordura hepática: avaliação de diferentes estratégias de medidas pela ressonância magnética nos casos de distribuição homogênea e heterogênea
Eloa de Castro Noguerol, Luis Ronan Marquez Ferreira de Souza, Valdair Francisco Muglia, Jorge Elias Jr.
Radiologia Brasileira.2024;[Epub] CrossRef Quantification of hepatic fat: evaluation of different magnetic resonance imaging measurement strategies in cases of homogeneous and heterogeneous distribution
Eloa de Castro Noguerol, Luis Ronan Marquez Ferreira de Souza, Valdair Francisco Muglia, Jorge Elias Jr.
Radiologia Brasileira.2024;[Epub] CrossRef LDHA- Mediated Histone Lactylation Promotes the Nonalcoholic Fatty Liver Disease Progression Through Targeting The METTL3/ YTHDF1/SCD1 m6A Axis
J Meng, C Yan, J Liu
Physiological Research.2024; : 985. CrossRef Efficacy of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Xiangyu Zhou, Jincheng Wang, Sufang Zhou, Jiajia Liao, Zuoyu Ye, Leiming Mao
Medicine.2023; 102(4): e32734. CrossRef Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Eileen Laurel Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(2): 371. CrossRef The growing burden of non-alcoholic fatty liver disease on mortality
Ju-Yeon Cho, Won Sohn
Clinical and Molecular Hepatology.2023; 29(2): 374. CrossRef Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
Heejoon Jang, Won Kim
Clinical and Molecular Hepatology.2023; 29(2): 381. CrossRef MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study
Eugene Han, Ho Soo Chun, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Sang Hoon Ahn, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(9): 1598. CrossRef Moderate- and High-Intensity Endurance Training Alleviate Diabetes-Induced Cardiac Dysfunction in Rats
Sarah D’Haese, Maxim Verboven, Lize Evens, Dorien Deluyker, Ivo Lambrichts, BO Eijnde, Dominique Hansen, Virginie Bito
Nutrients.2023; 15(18): 3950. CrossRef Waiting for the changes after the adoption of steatotic liver disease
Eileen L. Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(4): 844. CrossRef Letter regarding “Risk factors in nonalcoholic fatty liver disease”
Abhijit Pratap, Umesh More, Pradnya Phalak, Anita Deshmukh
Clinical and Molecular Hepatology.2023; 29(4): 1046. CrossRef Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Choe
Clinical and Molecular Hepatology.2023; 29(4): 987. CrossRef Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
Eileen L. Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(4): 1050. CrossRef Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: a single-centre retrospective study
Fengqin Yan, Guqiao Nie, Nianli Zhou, Meng Zhang, Wen Peng
BMJ Open.2023; 13(10): e072489. CrossRef International diet quality index and revised diet quality index relationship with non-alcoholic fatty liver disease: a case-control study
Narjes Najibi, Mitra Kazemi Jahromi, Farshad Teymoori, Hossein Farhadnejad, Ammar Salehi-Sahlabadi, Parvin Mirmiran
BMC Gastroenterology.2023;[Epub] CrossRef
|